- Home
- FHTX vs SMTI Comparison
FHTX vs SMTI Comparison
Compare FHTX & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- SMTI
- Stock Information
- Founded
- FHTX 2015
- SMTI 1982
- Country
- FHTX United States
- SMTI United States
- Employees
- FHTX N/A
- SMTI N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- SMTI Medical/Dental Instruments
- Sector
- FHTX Health Care
- SMTI Health Care
- Exchange
- FHTX Nasdaq
- SMTI Nasdaq
- Market Cap
- FHTX 278.1M
- SMTI 243.3M
- IPO Year
- FHTX 2020
- SMTI N/A
- Fundamental
- Price
- FHTX $5.06
- SMTI $33.66
- Analyst Decision
- FHTX Strong Buy
- SMTI Strong Buy
- Analyst Count
- FHTX 6
- SMTI 2
- Target Price
- FHTX $11.33
- SMTI $50.00
- AVG Volume (30 Days)
- FHTX 87.3K
- SMTI 40.6K
- Earning Date
- FHTX 08-05-2025
- SMTI 08-13-2025
- Dividend Yield
- FHTX N/A
- SMTI N/A
- EPS Growth
- FHTX N/A
- SMTI N/A
- EPS
- FHTX N/A
- SMTI N/A
- Revenue
- FHTX $24,173,000.00
- SMTI $97,241,894.00
- Revenue This Year
- FHTX $43.75
- SMTI $24.49
- Revenue Next Year
- FHTX $1.27
- SMTI $14.43
- P/E Ratio
- FHTX N/A
- SMTI N/A
- Revenue Growth
- FHTX N/A
- SMTI 34.29
- 52 Week Low
- FHTX $2.95
- SMTI $23.53
- 52 Week High
- FHTX $10.25
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- FHTX 47.33
- SMTI 66.25
- Support Level
- FHTX $5.16
- SMTI $29.33
- Resistance Level
- FHTX $5.63
- SMTI $34.10
- Average True Range (ATR)
- FHTX 0.35
- SMTI 1.54
- MACD
- FHTX 0.01
- SMTI 0.48
- Stochastic Oscillator
- FHTX 38.83
- SMTI 90.30
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.